Back to Search Start Over

A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency.

Authors :
Xie H
Wang M
Jin Y
Li X
Jiang S
Yang L
Source :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2022 Sep 01; Vol. 33 (6), pp. 337-341.
Publication Year :
2022

Abstract

The objective of the study was to analyse a novel F13A1 gene mutation in a Chinese patient with factor XIII (FXIII) deficiency and explore the molecular mechanism. Pedigree investigation, clinical diagnosis, phenotypic and genetic analysis were conducted. The F13A1 gene was amplified by PCR and directly sequenced. Online bioinformatics software was needed to analyse the mutation. A novel mutation c.515G>C (p.Arg208Pro) in exon 4 was found in the proband. Protein Arg208 is conserved highly among homologous species. Bioinformatics software showed that Arg208Pro mutation might affect the protein function. We preliminarily believed the mutation Arg208Pro was responsible for the decrease FXIII level. We reported a novel mutation in the F13A1 gene, which can flesh out the mutant library.<br /> (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1473-5733
Volume :
33
Issue :
6
Database :
MEDLINE
Journal :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Publication Type :
Academic Journal
Accession number :
35981255
Full Text :
https://doi.org/10.1097/MBC.0000000000001143